Innophos Holdings, a producer of specialty phosphate salts and acids, announced the terms for its IPO on Friday. The New Jersey-based company plans to offer 8.7 million shares at a range of $14-$16. The deal has a proposed market cap of $283 million and is expected to price the week of October 30th. Credit Suisse, Bear Stearns and UBS are managing the deal.
